Negative Patient Care Perceptions Linked to Increased Number of Pre-diagnostic Consultations
the Cancer Therapy Advisor take:
There is a negative association between multiple pre-referral consultations with a general practitioner and the patient experience of subsequent cancer care, according to an article published online in the European Journal of Cancer Care.
The study included data from 73,462 respondents to two English Cancer Patient Experience Surveys. The authors evaluated the likelihood of patients reporting negative experiences of subsequent care after three or more (3+) pre-referral consultations compared to one or two consultations.
Results showed a strong correlation (P<0.01 for all) between patients with 3+ pre-referral consultations and perceived worse care experiences (for 10/12 questions), compared to those with 1-2 consultations ranging from 1.10 to 1.68 (95% CI: 1.03, 1.17 vs. 1.60-1.77, respectively).
In other words, patients with 3+ consultations had a +1.8% to +10.6% greater percentage of reporting a negative subsequent care experience than those with 1-2 visits.
The associations were reported to be stronger when related to primary care as opposed to hospital care, and for evaluation than report items.
Furthermore, a “dose-response” relationship was found after considering 1, 2, 3-4, and 5+ pre-referral consultations separately.
There is a negative association between multiple pre-referral consultations with a general practitioner and the patient experience.
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- Pancreatitis and the Risk of Cancer
- RAMIE May Improve Post-operative Outcomes Among Patients With Esophageal Cancer
- Hyperthermic Intraperitoneal Chemotherapy With Cytoreductive Surgery Prolongs OS in Gastric Cancer
- Renal Cell Carcinoma: Cost of Treatment May Negate Impact of Treatment Advances
- Pembrolizumab May Be Effective for Previously Treated Hepatocellular Carcinoma
- CTC Screening May Be Effective Method for Preventing Colorectal Cancer
- Physical Activity Intervention May Improve Functional Well-being Among CRC Survivors
- Atezolizumab With Cobimetinib Yields Partial Response in Small Number of Patients With CRC
- Nivolumab May Improve Long-term Complete Response Rate in Subset of Patients With mCRC
- Alcohol Consumption and Cancer